Boston Scientific Corp. (BSX)

Index:

S&P 500

$ 102.09
   
  • Change Today:
    $-0.74
  • 52 Week High: $106.66
  • 52 Week Low: $72.96
  • Currency: US Dollars
  • Shares Issued: 1,474.56m
  • Volume: 9,114,617
  • Market Cap: $150,537m
  • RiskGrade: 132
  • Beta: 0.76

Fundamentals - based on IFRS

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Income Statement 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Continuing Operations          
Revenue 16,747.00 14,240.00 12,682.00 1,888.00 9,913.00
Operating Profit/(Loss) 2,603.00 2,343.00 1,649.00 1,199.00 (80.00)
Profit Before Tax 2,282.00 1,985.00 1,141.00 1,076.00 (79.00)
Profit After Tax 1,846.00 1,592.00 698.00 1,041.00 (82.00)
           
Earnings per Share - Basic 126.00¢ 108.00¢ 45.00¢ 69.00¢ (8.00¢)
Earnings per Share - Adjusted 126.00¢ 108.00¢ 45.00¢ 69.00¢ (8.00¢)
           
Dividend per Share n/a n/a n/a n/a n/a
  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Assets          
Non-Current Assets          
Property, Plant & Equipment 3,294.00 2,859.00 2,446.00 2,252.00 2,084.00
Intangible Assets 23,773.00 20,390.00 18,822.00 18,109.00 15,868.00
Other Non-Current Assets 5,409.00 5,372.00 5,442.00 5,552.00 6,131.00
  32,476.00 28,621.00 26,710.00 25,913.00 24,083.00
Current Assets          
Inventories 2,810.00 2,484.00 1,867.00 1,610.00 1,351.00
Cash at Bank & in Hand 414.00 865.00 928.00 1,925.00 1,734.00
Other Current Assets 3,695.00 3,165.00 2,965.00 2,782.00 3,609.00
  6,919.00 6,514.00 5,760.00 6,317.00 6,694.00
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 39,395.00 35,135.00 32,470.00 32,230.00 30,777.00
Current Liabilities          
Borrowings 1,778.00 531.00 n/a 261.00 13.00
Other Current Liabilities 4,621.00 4,402.00 3,803.00 4,013.00 3,669.00
           
Current Liabilities 6,399.00 4,933.00 3,803.00 4,274.00 3,682.00
           
Net Current Assets c520.00 c1,581.00 c1,957.00 c2,043.00 c3,012.00
           
Borrowings 8,968.00 8,571.00 8,915.00 8,804.00 9,130.00
Other Non-Current Liabilities 2,025.00 2,101.00 2,179.00 2,530.00 2,639.00
Non-Current Liabilities 10,993.00 10,672.00 11,094.00 11,334.00 11,769.00
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 17,392.00 15,605.00 14,897.00 15,608.00 15,451.00
           
Net Assets 22,003.00 19,530.00 17,573.00 16,622.00 15,326.00
           
Shareholders Funds 21,770.00 19,282.00 17,573.00 16,622.00 15,326.00
           
Minority Interests/Other Equity 233.00 248.00 n/a n/a n/a
Total Equity 22,003.00 19,530.00 17,573.00 16,622.00 15,326.00
Cash Flow 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Net Cash Flow From Operating Activities 3,435.00 2,503.00 1,526.00 1,870.00 1,508.00
Net Cash Flow from Investing Activities (5,687.00) (2,574.00) (2,011.00) (1,598.00) (411.00)
Net Cash Flow from Financing Activities 1,803.00 1.00 (557.00) (101.00) 291.00
Net Increase/Decrease In Cash (449.00) (70.00) (1,042.00) 171.00 1,388.00
Ratios - based on IFRS 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Continuing Operations          
PE Ratio - Adjusted 70.9 53.5 102.8 61.6 n/a
PEG - Adjusted 4.2 0.4 n/a n/a n/a
Earnings per Share Growth - Adjusted 17% 140% -35% n/a n/a
Dividend Cover n/a n/a n/a n/a n/a
Revenue per Share 1,135.73¢ 965.71¢ 860.06¢ 128.04¢ 672.27¢
Pre-Tax Profit per Share 154.76¢ 134.62¢ 77.38¢ 72.97¢ (5.36¢)
Operating Margin 15.54% 16.45% 13.00% 63.51% (0.81%)
Return on Capital Employed 25.42% 24.08% 14.88% 14.20% n/a
           
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a n/a
Operating Cash Flow per Share 232.95¢ 169.75¢ 103.49¢ 126.82¢ 102.27¢
Cash Incr/Decr per Share (30.45¢) (4.75¢) (70.67¢) 11.60¢ 94.13¢
Net Asset Value per Share (exc. Intangibles) (120.04¢) (58.32¢) (84.70¢) (100.84¢) (36.76¢)
Net Gearing 47.46% 42.72% 45.45% 42.96% 48.34%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Top of Page